KDNY - Chinook Therapeutics GAAP EPS of -$0.90 misses by $0.11 revenue of $0.51M beats by $0.41M February, 27 2023 04:05 PM Chinook Therapeutics Inc Com Chinook Therapeutics press release ( NASDAQ: KDNY ): Q4 GAAP EPS of -$0.90 misses by $0.11 . Revenue of $0.51M beats by $0.41M . For further details see: Chinook Therapeutics GAAP EPS of -$0.90 misses by $0.11, revenue of $0.51M beats by $0.41M